SK
Sunil Kumar
About Sunil Kumar
Data last updated:
Sunil Kumar is a Director at Ambrons Pharma Private Limited (since 2019), Designated Partner at Biosalt Pharmaceuticals Llp (since 2026) and Director at Emsense Biosciences Private Limited (since 2018). The companies operate in Healthcare, Pharma and Business Services. The largest current company by reported revenue is Ambrons Pharma Private Limited at ₹36.6 Lakh (FY 2022). Earlier, Sunil Kumar was a Director at Kartilaze Care Limited (2018) and Director at Cartilaze Care India Private Limited (from 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Jun 2019 | 2015 | ₹36.6 Lakh (FY 2022) | Active | |
| Designated Partner | 25 Feb 2026 | 2026 | Active | ||
| Director | 14 Dec 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Mar 2018 | 2018 | Active | ||
| Director | 14 Jan 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sunil Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Kumar | 07011240 | Ambrons Pharma Private Limited | Director |
| Balbir Singh | 07011235 | Ambrons Pharma Private Limited | Director |
| Narottam Aggarwal | 11510961 | Biosalt Pharmaceuticals Llp | Designated Partner |
| Kul Bhushan Sharma | 08104392 | Emsense Biosciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Kumar
Sunil Kumar currently holds 3 directorships: Ambrons Pharma Private Limited (Director, since 14 Jun 2019, revenue ₹36.6 Lakh (FY 2022)); Biosalt Pharmaceuticals Llp (Designated Partner, since 25 Feb 2026); Emsense Biosciences Private Limited (Director, since 14 Dec 2018).
Sunil Kumar was first appointed on 06 Mar 2018 as Director at Kartilaze Care Limited. The most recent appointment on record is 25 Feb 2026 at Biosalt Pharmaceuticals Llp.
Sunil Kumar held 2 earlier board appointments: Kartilaze Care Limited (Director, 06 Mar 2018 to 13 Oct 2018); Cartilaze Care India Private Limited (Director, from 14 Jan 2020).
The current boards of Sunil Kumar's companies include Anil Kumar (Ambrons Pharma Private Limited), Balbir Singh (Ambrons Pharma Private Limited), Narottam Aggarwal (Biosalt Pharmaceuticals Llp), Kul Bhushan Sharma (Emsense Biosciences Private Limited).